대한본초학회지 (The Korea Journal of Herbology)

  • 제26권4호
  • /
  • Pages.169-180
  • /
  • 2011
  • /
  • 1229-1765(pISSN)
  • /
  • 2288-7199(eISSN)
대한본초학회 (The Korea Association of Herbology)
권호 표지
DOI QR코드

DOI QR Code

홍경천(紅景天)이 뇌조직내출혈(腦組織內出血) 흰쥐의 뇌부종(腦浮腫)과 Matrix Metalloproteinase 발현에 미치는 영향

Effects of Rhodiola Rosea on Brain Edema and Matrix Metalloproteinase Expressions Following Intracerebral Hemorrhage in the Rat

  • 류사현 (경희대학교 동서의학대학원 한의과학) ;
  • 이준석 (경희대학교 동서의학대학원 한의과학) ;
  • 신정원 (경희대학교 동서의학대학원 한의과학) ;
  • 김성준 (경희대학교 동서의학대학원 한의과학) ;
  • 손낙원 (경희대학교 동서의학대학원 한의과학)
  • Ryu, Sa-Hyun (Dept. of Oriental Medical Science, Graduate School of East-West Medical Science, Kyung Hee University) ;
  • Lee, Joon-Suk (Dept. of Oriental Medical Science, Graduate School of East-West Medical Science, Kyung Hee University) ;
  • Shin, Jung-Won (Dept. of Oriental Medical Science, Graduate School of East-West Medical Science, Kyung Hee University) ;
  • Kim, Seong-Joon (Dept. of Oriental Medical Science, Graduate School of East-West Medical Science, Kyung Hee University) ;
  • Sohn, Nak-Won (Dept. of Oriental Medical Science, Graduate School of East-West Medical Science, Kyung Hee University)
  • 투고 : 2011.08.31
  • 심사 : 2011.12.16
  • 발행 : 2011.12.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives : This study aimed at evaluation of the effects of Rhodiola rosea on brain edema and expressions of matrix metalloproteinases (MMPs) related to blood-brain barrier (BBB) disruption. Methods : Brain edema following intracerebral hemorrhage (ICH) was induced by the stereotaxic intrastriatal injection of bacterial collagenase type VII in rats (Sprague-Dawley). Then ethanol extract of Rhodiola rosea was treated once a day for 3 days. Brain edema % and water contents, and BBB leakage were examined. Immunohistochemistry was processed for MMP-9, MMP-12, and iNOS expressions in the brain sections and each immuno-labeled cells were analyzed with image analysis software. Results : 1. Ethanol extract of Rhodiola rosea reduced brain edema following ICH in rats significantly. 2. Ethanol extract of Rhodiola rosea reduced excessive brain tissue water contents following ICH in rats significantly. 3. Ethanol extract of Rhodiola rosea reduced BBB leakage in the cerebral cortex following ICH in rats. 4. Ethanol extract of Rhodiola rosea reduced cellular edema of neurons in peri-hematoma and the cerebral cortex following ICH in rats significantly. 5. Ethanol extract of Rhodiola rosea reduced MMP-9 positive cells in the cerebral cortex following ICH in rats significantly. 6. Ethanol extract of Rhodiola rosea reduced MMP-12 positive vessels in the cerebral cortex following ICH in rats significantly. 7. Ethanol extract of Rhodiola rosea reduced iNOS positive cells in the cerebral cortex and external capsule following ICH in rats significantly. Conclusions : These results suggest that Rhodiola rosea reveals protective effect against brain edema and cytotoxic edema of neurons by means of down-regulation of MMPs and iNOS expressions, and inhibition of BBB leakage.

키워드

참고문헌

  1. Byung-Chul Lee, Kyung-Ho Yu. Epidemiology of Stroke in Korea. J. Korean Med. Association. 2002 ; 45 : 1415-21. https://doi.org/10.5124/jkma.2002.45.12.1415
  2. Badjatia N, Rosand J. Intracerebral hemorrhage. Neurologist. 2005 ; 11(6) : 311-24. https://doi.org/10.1097/01.nrl.0000178757.68551.26
  3. Xi G, Keep RF, Hoff JT. Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol. 2006 ; 5(1) : 53-63. https://doi.org/10.1016/S1474-4422(05)70283-0
  4. Grant JS, Elliott TR, Weaver M, Glandon GL, Raper JL, Giger JN. Social support, social problem-solving abilities, and adjustment of family caregivers of stroke survivors. Arch Phys Med Rehabil. 2006 ; 87(3) : 343-50. https://doi.org/10.1016/j.apmr.2005.09.019
  5. Lo YK, Yiu CH, Hu HH, Su MS, Laeuchli SC. Frequency and characteristics of early seizures in Chinese acute stroke. Acta Neurol Scand. 1994 ; 90(2) : 83-5.
  6. Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS. Intracerebral hemorrhage versus infarction : stroke severity, risk factors, and prognosis. Ann Neurol. 1995 ; 38(1) : 45-50. https://doi.org/10.1002/ana.410380110
  7. Joon Heo. Dongeuibogam. Seoul : Namsandang. 1998 : 509-19.
  8. Young-Suk Kim. Pathogenesis and Pathology of Stroke. J. Oriental Chronic Dis. 1995 ; 1(1) : 113-40.
  9. Kelly GS. Rhodiola rosea : a possible plant adaptogen. Altern Med Rev. 2001 ; 6(3) : 293-302.
  10. Ming DS, Hillhouse BJ, Guns ES, Eberding A, Xie S, Vimalanathan S, Towers GH. Bioactive compounds from Rhodiola rosea (Crassulaceae). Phytother Res. 2005 ; 19(9) : 740-3. https://doi.org/10.1002/ptr.1597
  11. Chinese Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China. Beijing : Press of Chemistry and Industry. 2000 : 27.
  12. Editors of The State Administration of Chinese Materia Medica(中華本草). Chinese Materia Medica (中華本草). Shanghai : Shanghai Press of Science and Technology. 1999 : 763.
  13. Rong-han Zhou. Resource Science of Chinese Medicinal Materials. Beijing : Press of Chinese Medicine and Technology. 1987 : 83-5.
  14. Kanupriya, Prasad D, Sai Ram M, Kumar R, Sawhney RC, Sharma SK, Ilavazhagan G, Kumar D, Banerjee PK. Cytoprotective and antioxidant activity of Rhodiola imbricata against tert-butyl hydroperoxide induced oxidative injury in U-937 human macrophages. Mol Cell Biochem. 2005 ; 275(1-2) : 1-6. https://doi.org/10.1007/s11010-005-7637-1
  15. Darbinyan V, Kteyan A, Panossian A, Gabrielian E, Wikman G, Wagner H. Rhodiola rosea in stress induced fatigue-a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine. 2000 ; 7(5) : 365-71. https://doi.org/10.1016/S0944-7113(00)80055-0
  16. Shevtsov VA, Zholus BI, Shervarly VI, Vol'skij VB, Korovin YP, Khristich MP, Roslyakova NA, Wikman G. A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work. Phytomedicine. 2003 ; 10(2-3) : 95-105. https://doi.org/10.1078/094471103321659780
  17. Mook-Jung I, Kim H, Fan W, Tezuka Y, Kadota S, Nishijo H, Jung MW. Neuroprotective effects of constituents of the oriental crude drugs, Rhodiola sacra, R. sachalinensis and Tokaku-joki-to, against beta-amyloid toxicity, oxidative stress and apoptosis. Biol Pharm Bull. 2002 ; 25(8) : 1101-4. https://doi.org/10.1248/bpb.25.1101
  18. Petkov VD, Yonkov D, Mosharoff A, Kambourova T, Alova L, Petkov VV, Todorov I. Effects of alcohol aqueous extract from Rhodiola rosea L. roots on learning and memory. Acta Physiol Pharmacol Bulg. 1986 ; 12(1) : 3-16.
  19. Abidov M, Crendal F, Grachev S, Seifulla R, Ziegenfuss T. Effect of extracts from Rhodiola rosea and Rhodiola crenulata (Crassulaceae) roots on ATP content in mitochondria of skeletal muscles. Bull Exp Biol Med. 2003 ; 136(6) : 585-7. https://doi.org/10.1023/B:BEBM.0000020211.24779.15
  20. Rosenberg GA, Mun-Bryce S, Wesley M, Kornfeld M. Collagenase induced intracerebral hemorrhage in rats. Stroke. 1990 ; 21 : 801-7. https://doi.org/10.1161/01.STR.21.5.801
  21. Alexander JJ, Jacob A, Cunningham P, Hensley L, Quigg RJ. TNF is a key mediator of septic encephalopathy acting through its receptor, TNF receptor-1. Neurochem Int. 2008 ; 52(3) : 447-56. https://doi.org/10.1016/j.neuint.2007.08.006
  22. Provalova NV, Skurikhin EG, Pershina OV, Suslov NI, Minakova MY, Dygai AM, Goldberg ED. Mechanisms underling the effects of adaptogens on erythropoiesis during paradoxical sleep deprivation. Bull Exp Biol Med. 2002 ; 133(5) : 428-32. https://doi.org/10.1023/A:1019837015668
  23. Brekhman II, Dardymov IV. New substances of plant origin which increase nonspecific resistance. Ann Rev Pharmacol. 1969 ; 9 : 419-30. https://doi.org/10.1146/annurev.pa.09.040169.002223
  24. Ganzera M, Yayla Y, Khan IA. Analysis of the marker compounds of Rhodiola rosea L. (golden root) by reversed phase high performance liquid chromatography. Chem Pharm Bull. 2001 ; 49(4) : 465-7. https://doi.org/10.1248/cpb.49.465
  25. Tolonen A, Pakonen M, Hohtola A, Jalonen J. Phenylpropanoid glycosides from Rhodiola rosea. Chem Pharm Bull. 2003 ; 51(4) : 467-70. https://doi.org/10.1248/cpb.51.467
  26. Linh PT, Kim YH, Hong SP, Jian JJ, Kang JS. Quantitative determination of salidroside and tyrosol from the underground part of Rhodiola rosea by high performance liquid chromatography. Arch Pharm Res. 2000 ; 23(4) : 349-52. https://doi.org/10.1007/BF02975446
  27. Begley DJ, Brightman MW. Structural and functional aspects of the blood-brain barrier. Prog Drug Res. 2003 ; 61 : 39-78.
  28. Abbott NJ, Ronnback L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci. 2006 ; 7(1) : 41-53. https://doi.org/10.1038/nrn1824
  29. Feuerstein GZ, Wang X, Barone FC. The role of cytokines in the neuropathology of stroke and neurotrauma. Neuroimmunomodulation. 1998 ; 5(3-4) : 143-59. https://doi.org/10.1159/000026331
  30. Unterberg AW, Stover J, Kress B, Kiening KL. Edema and brain trauma. Neuroscience. 2004 ; 129(4) : 1021-9.
  31. Tran ND, Correale J, Schrieber SS, Fisher M. Transforming growth factor-$\beta$ mediates astrocyte specific regulation of brain endothelial anticoagulant factors. Stroke. 1999 ; 30 : 1671-7. https://doi.org/10.1161/01.STR.30.8.1671
  32. Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nature Rev Neurosci. 2003 ; 4 : 399-415.
  33. Xi G, Keep RF, Hoff JT. Pathophysiology of brain edema formation. Neurosurg Clin N Am. 2002 ; 13 : 371-83. https://doi.org/10.1016/S1042-3680(02)00007-4
  34. Mun-Bryce S, Rosenberg GA. Matrix metalloproteinases in cerebrovascular disease. J Cereb Blood Flow Metab. 1998 ; 18 : 1163-72. https://doi.org/10.1097/00004647-199811000-00001
  35. Lapchak PA, Chapman DF, Zivin JA. Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke. Stroke. 2000 ; 31 : 3034-40. https://doi.org/10.1161/01.STR.31.12.3034
  36. Seeds NW, Siconolfi LB, Haffke SP. Neuronal extracellular proteases facilitate cell migration, axonal growth, and pathfinding. Cell Tissue Res. 1997 ; 290 : 367-70. https://doi.org/10.1007/s004410050942
  37. Rosenberg GA. Matrix metalloproteinases in neuroinflammation. Glia. 2002 ; 39 : 279-91. https://doi.org/10.1002/glia.10108
  38. Yong VW, Power C, Forsyth P, Edwards DR. Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci. 2001 ; 2 : 502-11. https://doi.org/10.1038/35081571
  39. Power C, Henry S, Del Bigio MR, Larsen PH, Corbett D, Imai Y, Yong VW, Peeling J. Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases. Ann Neurol. 2003 ; 53 : 731-42. https://doi.org/10.1002/ana.10553
  40. Liu K, Mori S, Takahashi HK, Tomono Y, Wake H, Kanke T, Sato Y, Hiraga N, Adachi N, Yoshino T, Nishibori M. Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. FASEB J. 2007 ; 21(14) : 3904-16. https://doi.org/10.1096/fj.07-8770com